Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma
Clinical trial NCT07747935 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07747935
- Sponsor
- ReBio Pharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.